Kynurenic / Quinolinic Ratio

Optimal result: 0.44 – 5 Ratio

High KYNA/QA Ratio: Understanding the Benefits

A high Kynurenic Acid (KYNA) to Quinolinic Acid (QA) ratio (K/Q ratio) is generally considered beneficial, contrary to some misconceptions. This balance suggests a shift in tryptophan metabolism towards a more neuroprotective state.

Benefits of a High K/Q Ratio

  1. Enhanced Neuroprotection
    • KYNA acts as an endogenous neuroprotective agent .
    • Higher levels of KYNA relative to QA may help protect against neurotoxicity and excitotoxicity .
  2. Improved Brain Health
    • Associated with better white matter integrity in the brain .
    • May contribute to cognitive resilience and neuroplasticity .
  3. Potential Factors Contributing to a High K/Q Ratio
    • Vitamin B6 supplementation, which supports KYNA synthesis .
    • Reduced QA synthesis, often associated with lower inflammation .

Common Misunderstandings

It's crucial to differentiate between various metabolic ratios in the kynurenine pathway:

  1. K/Q Ratio (KYNA/QA)
    • A high ratio is generally beneficial.
    • Indicates a balance favoring neuroprotection over neurotoxicity.
  2. QA/5-HIAA Ratio
    • Often confused with the K/Q ratio.
    • A high QA/5-HIAA ratio may indicate immune overstimulation or other health issues .
    • This ratio reflects the balance between the kynurenine pathway and serotonin synthesis.

Implications for Health

Understanding the K/Q ratio can provide insights into:

  • Neuroinflammatory status
  • Potential risk for neurodegenerative conditions
  • Overall balance of the kynurenine pathway

Conclusion

While a high K/Q ratio is generally positive, it's essential to consider it in the context of overall health and other biomarkers. Optimal levels may vary between individuals, and interpretation should be done in consultation with a healthcare professional.

Understanding and Improving the Kynurenic Acid to Quinolinic Acid Ratio (K/Q Ratio)

A low Kynurenic Acid (KYNA) to Quinolinic Acid (QA) ratio (K/Q ratio) indicates a shift in tryptophan metabolism towards a more neurotoxic and inflammatory state. This imbalance is often associated with neuroinflammation, excitotoxicity, oxidative stress, and disorders such as depression, anxiety, neurodegenerative diseases, and chronic infections.

Approach to Improving a Low K/Q Ratio

The goal is to increase KYNA levels (which has neuroprotective effects) while reducing QA levels (which contributes to neurotoxicity and inflammation). It's important to note that individual responses may vary, and a personalized approach under the guidance of a healthcare professional is recommended.

1. Support Tryptophan Metabolism Towards KYNA Production

  • Niacin (Vitamin B3) (500–1000 mg/day)
    • Helps divert tryptophan metabolism away from quinolinic acid production .
    • Supports NAD+ synthesis, which reduces oxidative stress.
  • Vitamin B6 (P5P form) (25–50 mg/day)
    • Required for proper kynurenine metabolism .
    • Deficiency can push metabolism toward QA.
  • Magnesium (200–400 mg/day)
    • Supports enzymatic balance in the kynurenine pathway .
    • Reduces excitotoxicity by blocking NMDA receptors.
  • Zinc (15–30 mg/day)
    • Regulates inflammation and inhibits the enzyme IDO (indoleamine 2,3-dioxygenase), which pushes tryptophan toward QA production .

2. Reduce Inflammation and Oxidative Stress

  • Antioxidants
    • N-acetylcysteine (NAC) (600–1200 mg/day) – boosts glutathione and reduces oxidative stress .
    • Alpha-lipoic acid (ALA) (300–600 mg/day) – supports mitochondrial health and reduces QA formation .
    • Resveratrol (100–300 mg/day) – anti-inflammatory and neuroprotective .
    • Curcumin (500–1000 mg/day) – reduces neuroinflammation by modulating NF-kB and cytokines .
  • Omega-3 Fatty Acids (EPA/DHA)
    • (1000–2000 mg/day) – reduces inflammation and improves neuroprotection .
  • Green Tea (EGCG)
    • Helps inhibit neuroinflammation and reduces oxidative stress .

3. Modulate the Immune System

  • Reduce Chronic Infections
    • Infections can activate IDO, driving tryptophan metabolism toward quinolinic acid .
    • Address underlying bacterial (e.g., Lyme disease), viral (e.g., EBV), or fungal infections.
  • Control Autoimmunity & Gut Health
    • Probiotics and Prebiotics – Support gut health, as microbiome imbalances can affect tryptophan metabolism .
    • Low-inflammatory Diet – Avoid processed foods, excess sugar, and inflammatory triggers.

4. Balance Neurotransmitters

  • L-Theanine (100–200 mg/day) – Promotes relaxation by modulating glutamate .
  • GABA-supporting supplements (e.g., magnesium, taurine) – Help counter excitotoxicity.
  • 5-HTP or Tryptophan Supplements (if serotonin is low) – Should be used cautiously to avoid excess conversion to QA.

5. Lifestyle Interventions

  • Manage Stress – Chronic stress elevates inflammatory cytokines that drive quinolinic acid production .
  • Improve Sleep Quality – Poor sleep can worsen neuroinflammation .
  • Exercise – Regular aerobic exercise increases KYNA levels and reduces QA .

Precautions and Considerations

  • Supplement Interactions: Some supplements may interact with medications or each other. For example, NAC can interact with certain blood pressure medications, and high-dose niacin may affect blood sugar levels .
  • Individual Variability: Response to these interventions can vary based on genetics, overall health status, and other factors. Regular monitoring and adjustments may be necessary.
  • Underlying Conditions: If the K/Q imbalance is related to chronic infections, autoimmune conditions, or neurodegenerative diseases, addressing these underlying issues is crucial.

Final Thoughts

A low K/Q ratio is typically driven by chronic inflammation, oxidative stress, and metabolic dysfunction. The approach focuses on reducing neurotoxicity (QA) and enhancing neuroprotection (KYNA) through targeted nutrients, anti-inflammatory support, and lifestyle modifications. If the imbalance is severe or linked to a specific condition, working with a functional medicine practitioner can help tailor interventions further and ensure safe implementation of any supplement regimen.

Kynurenic acid, which is derived from the processing of tryptophan, is converted to quinolinic acid in the presence of B6 or P5P. While kynurenic is calming, quinolinic is an excitotoxin that can over stimulate nerves. 

Kynurenic Acid to Quinolinic Acid Ratio: Understanding Its Health Implications

The Kynurenic Acid to Quinolinic Acid (KA/QA) ratio is a critical biomarker in tryptophan metabolism, providing valuable insights into neurological health and inflammation. This ratio compares levels of two key metabolites:

  1. Kynurenic Acid (KA): A neuroprotective compound
  2. Quinolinic Acid (QA): A potentially neurotoxic substance

Clinical Significance

Healthcare providers utilize the KA/QA ratio to:

  • Assess neuroinflammation
  • Evaluate metabolic dysfunction
  • Guide treatment strategies for neurological conditions

A higher KA/QA ratio is generally considered beneficial, indicating a shift towards neuroprotection. Conversely, a lower ratio may suggest increased neurotoxicity and inflammation.

Health Implications

  1. Neurological Health: A higher KA/QA ratio is associated with better white matter integrity in the brain and may contribute to cognitive resilience.
  2. Mental Health: A reduced KA/QA ratio has been observed in both currently depressed and remitted patients with Major Depressive Disorder (MDD) compared to healthy controls.
  3. Inflammation: The KA/QA ratio is influenced by inflammatory processes, with higher inflammation potentially leading to increased QA production.
  4. Excitotoxicity: A lower KA/QA ratio may indicate higher excitotoxic potential, particularly relevant in conditions like Multiple Sclerosis.

Improving Your KA/QA Ratio

To maintain a healthy KA/QA balance:

  1. Manage stress levels: Chronic stress can elevate inflammatory cytokines that drive quinolinic acid production.
  2. Maintain a balanced diet: Focus on foods rich in tryptophan and anti-inflammatory nutrients.
  3. Consider vitamin B6 supplementation: Under medical supervision, as B6 supports proper kynurenine metabolism.
  4. Address underlying inflammation: Through lifestyle changes and targeted interventions.
  5. Regular exercise: Aerobic exercise may help increase KYNA levels and reduce QA.

Conclusion

Understanding your KA/QA ratio can provide valuable insights into your neurological and overall health. While a high ratio is generally considered beneficial, it's essential to consult with a healthcare professional for personalized interpretation of your results and appropriate interventions.

References:

1. Agudelo LZ, Femenía T, Orhan F, et al. Skeletal muscle PGC-1α1 modulates kynurenine metabolism and mediates resilience to stress-induced depression. Cell. 2014;159(1):33-45. doi:10.1016/j.cell.2014.07.051

2. Agus A, Planchais J, Sokol H. Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease. Cell Host Microbe. 2018;23(6):716-724. doi:10.1016/j.chom.2018.05.003

3. Badawy AA. Kynurenine Pathway of Tryptophan Metabolism: Regulatory and Functional Aspects. Int J Tryptophan Res. 2017;10:1178646917691938. doi:10.1177/1178646917691938

4. Cervenka I, Agudelo LZ, Ruas JL. Kynurenines: Tryptophan's metabolites in exercise, inflammation, and mental health. Science. 2017;357(6349):eaaf9794. doi:10.1126/science.aaf9794

5. Guillemin GJ. Quinolinic acid, the inescapable neurotoxin. FEBS J. 2012;279(8):1356-1365. doi:10.1111/j.1742-4658.2012.08485.x

6. Lovelace MD, Varney B, Sundaram G, et al. Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases. Neuropharmacology. 2017;112(Pt B):373-388. doi:10.1016/j.neuropharm.2016.03.024

7. Lugo-Huitrón R, et al. Kynurenines as modulators of synaptic function: implications for neurodegenerative disorders. Neuropharmacology. 2017;112(Pt B):292-304.

8. Maddison DC, Giorgini F. The kynurenine pathway and neurodegenerative disease. Semin Cell Dev Biol. 2015;40:134-141. doi:10.1016/j.semcdb.2015.03.002

9. Majewski M, Kozlowska A, Thoene M, Lepiarczyk E, Grzegorzewski WJ. Overview of the role of vitamins and minerals on the kynurenine pathway in health and disease. J Physiol Pharmacol. 2016;67(1):3-19.

10. Myint AM, Kim YK. Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis. Prog Neuropsychopharmacol Biol Psychiatry. 2014;48:304-313. doi:10.1016/j.pnpbp.2013.08.008

11. O'Farrell K, Harkin A. Stress-related regulation of the kynurenine pathway: Relevance to neuropsychiatric and degenerative disorders. Neuropharmacology. 2017;112(Pt B):307-323. doi:10.1016/j.neuropharm.2015.12.004

12. Reyes Ocampo J, Lugo Huitrón R, González-Esquivel D, et al. Kynurenines with neuroactive and redox properties: relevance to aging and brain diseases. Oxid Med Cell Longev. 2014;2014:646909. doi:10.1155/2014/646909

13. Savitz J. The kynurenine pathway: a finger in every pie. Mol Psychiatry. 2020;25(1):131-147. doi:10.1038/s41380-019-0414-4

14. Savitz J, Drevets WC, Wurfel BE, et al. Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder. Brain Behav Immun. 2015;46:55-59. doi:10.1016/j.bbi.2015.02.007

15. Schwarcz R, Bruno JP, Muchowski PJ, Wu HQ. Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci. 2012;13(7):465-477. doi:10.1038/nrn3257

16. Sorgdrager FJH, Naudé PJW, Kema IP, Nollen EA, Deyn PP. Tryptophan Metabolism in Inflammaging: From Biomarker to Therapeutic Target. Front Immunol. 2019;10:2565. doi:10.3389/fimmu.2019.02565

17. Strasser B, Becker K, Fuchs D, Gostner JM. Kynurenine pathway metabolism and immune activation: Peripheral measurements in psychiatric and co-morbid conditions. Neuropharmacology. 2017;112(Pt B):286-296. doi:10.1016/j.neuropharm.2016.02.030

18. Strasser B, Geiger D, Schauer M, et al. Probiotic Supplements Beneficially Affect Tryptophan-Kynurenine Metabolism and Reduce the Incidence of Upper Respiratory Tract Infections in Trained Athletes: A Randomized, Double-Blinded, Placebo-Controlled Trial. Nutrients. 2016;8(11):752. doi:10.3390/nu8110752

19. Yamada A, Akimoto H, Kagawa S, Guillemin GJ, Takikawa O. Proinflammatory cytokine interferon-γ increases induction of indoleamine 2,3-dioxygenase in monocytic cells primed with amyloid β peptide 1-42: implications for the pathogenesis of Alzheimer's disease. J Neurochem. 2009;110(3):791-800. doi:10.1111/j.1471-4159.2009.06175.x

Kynurenic / Quinolinic Ratio
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond Kynurenic / Quinolinic Ratio — 10,000+ markers explained
One Kynurenic / Quinolinic Ratio result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro